Cancer Tissue Diagnostics Market to Reach US$ 3,419.61 Mn at CAGR of 6.2% in 2027 | The Insight Partners

Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography

Publication Month: Jul 2019 | Report Code: TIPRE00005672 | No. of Pages: 159 | Category: Medical Device | Status: Published

The global cancer tissue diagnostics market is US$ 2,025.41 Mn in 2018 and is predicted to grow at a CAGR of 6.2% during the forecast period 2019 – 2027, to reach US$ 3,419.61 Mn by 2027.

 

Europe is the second largest geographic market and is expected to be the second most significant revenue contributor in forecast period. The region has witnessed several technological advancements in the field of healthcare by the incorporation of advanced cancer tissue diagnostics in order to increase the efficiency of treatments in the region. The growth is driven by factors such as prevalence of cancer in the countries, increased mortality rates as well as growth strategies adopted by the market players in the European countries.

 

Exhibit: Lucrative Regional Cancer Tissue Diagnostics Markets

 

Market Insights

Growing Cancer Prevalence across the Globe

 

Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer will be a burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.

 

Additionally, cancer is found to be commonly prevalent in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in the UK were due to cancer.

 

Furthermore, Asia Pacific region is also facing the problem of the growing prevalence of cancer. The top 15 countries with Cancer prevalence are Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia. According to the National Institute of Cancer Prevention and Research (NICPR), in 2018, in India, total deaths due to cancer were 784,821. These statistics determine an increase in the demand for advanced cancer diagnostics in various regions across the globe. Hence, driving the growth of the cancer tissue diagnostics market during the forecast period.

 

Growing Investments for Tissue Diagnostics

Tissue diagnostics is very crucial in cancer treatment. Cancer tissue diagnostics play a significant role in determining the treatment pace and procedure. Early detection can help in reducing the mortality rates of cancer; hence, medical professionals, market players as well as government authorities implementing new diagnostics and treatment facilities. Thus the rise in investments and better reimbursement policies favor the growth of the cancer tissue diagnostics market.

 

For instance, in September 2017, OncoStem Diagnostics, invested USD 6 million towards research and development to develop useful tests for brain, colon and oral cancer, and also to automate these tests. Furthermore, Fimmic, which is now, Aiforia Technologies Oy in 2017 invested €5 million to develop, WebMicroscope AI Cloud for tissue diagnostics. Fimmic’s WebMicroscope launched in early 2017, is a tissue diagnostic commercial platform that enables image analysis through deep learning artificial intelligence (AI). In 2019, the company launched AIforia cloud platform, which accelerates image processing and provides automated pathology image analysis. Thus the growing investments for cancer tissue diagnostics have led to the advent of breakthrough techniques, expecting to fuel the growth of the market.

 

Test Type Insights

The global cancer tissue diagnostics market by test type was led by immunohistochemical tests segment. In 2018, the immunohistochemical tests segment held a largest market share of the cancer tissue diagnostics market, by test type. In addition, the immunohistochemical tests segment is also expected to grow at the fastest rate during the coming years owing to cost effectiveness of the technique. Moreover, the technique is easily accessible, and growth in number of products based on technology. Additionally, the rising prevalence of cancer is a major factor for the growth of the diagnostic tests. The segment is also anticipated to witness growth at a significant rate during the forecast period, 2019 to 2027.

 

Exhibit: Cancer Tissue Diagnostics Market, by Test Type


Strategic Insights

There have been limited developments made in the cancer tissue diagnostics market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of cancer tissue diagnostics. For instance, in June 2019, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its PD-L1 IHC 22C3 pharmDx assay. The assay is approved to aim in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA (pembrolizumab), anti-PD-1 therapy manufactured by Merck. Also, during November 2018, Leica Biosystems, launched the latest PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform.

 

CANCER TISSUE DIAGNOSTICS – MARKET SEGMENTATION

 

 By Test Type

  • Immunohistochemical Tests
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Stomach Cancer
    • Others
  • In Situ Hybridization Tests
    • Breast Cancer
    • Lung Cancer
    • Bladder Cancer
    • Others

 

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

 

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Abbott
  • Enzo Life Sciences, Inc.
  • Agilent Technologies, Inc.
  • Cancer Genetics Inc.
  • Merck KGaA (Sigma-Aldrich Co. LLC)
  • Abcam plc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Cancer Tissue Diagnostics Market – By Test Type

1.3.2        Global Cancer Tissue Diagnostics Market – By Geography

2.             Global Cancer Tissue Diagnostics Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Cancer Tissue Diagnostics Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South & Central America PEST Analysis

5.             Global Cancer Tissue Diagnostics Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Growing Cancer Prevalence Across The Globe

5.1.2        New Product Launches & FDA Approvals

5.1.3        Growing Investments For Tissue Diagnostics

5.2       Key Market Restraints

5.2.1        High Cost Of Cancer Diagnostics

5.3       Key Market Opportunities

5.3.1        Emerging Markets in Developing Countries

5.4       Future Trends

5.4.1        Inclination Towards Personalized Medicine

5.5       Impact Analysis

6.             Cancer Tissue Diagnostics Market – Global Analysis

6.1       Global Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis

6.2       Global Cancer Tissue Diagnostics Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

7.             Global Cancer Tissue Diagnostics Market Analysis– by Test Type

7.1       Overview

7.2       Global Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)

7.3       Immunohistochemical Tests Market

7.3.1        Overview

7.3.2        Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3        Breast Cancer Market

7.3.3.1      Overview

7.3.3.2      Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4        Colorectal Cancer Market

7.3.4.1      Overview

7.3.4.2      Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.5        Prostate Cancer Market

7.3.5.1      Overview

7.3.5.2      Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.6        Stomach Cancer Market

7.3.6.1      Overview

7.3.6.2      Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.7        Others Market

7.3.7.1      Overview

7.3.7.2      Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       In Situ Hybridization Tests Market

7.4.1        Overview

7.4.2        Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        Breast Cancer Market

7.4.3.1      Overview

7.4.3.2      Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.4        Lung Cancer Market

7.4.4.1      Overview

7.4.4.2      Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.5        Bladder Cancer Market

7.4.5.1      Overview

7.4.5.2      Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.6        Others Market

7.4.6.1      Overview

7.4.6.2      Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.             Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

8.1       North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.1.1        North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.2        North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.2.1      North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.2.2      North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.3        North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

8.1.4        US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.4.1      US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.4.2      US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.4.2.1       US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.4.2.2       US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.5        Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.5.1      Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.5.2      Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.5.2.1       Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.5.2.2       Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.6        Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.6.1      Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.1.6.2      Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.1.6.2.1       Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.1.6.2.2       Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2       Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.2.1        Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.2        Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.2.1      Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.2.2      Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.3        Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.2.4        UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.4.1      UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.4.2      UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.4.2.1       UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.4.2.2       UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.5        Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.5.1      Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.5.2      Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.5.2.1       Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.5.2.2       Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.6        France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.6.1      France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.6.2      France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.6.2.1       France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.6.2.2       France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.7        Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.7.1      Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.7.2      Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.7.2.1       Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.7.2.2       Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.8        Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.8.1      Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.2.8.2      Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.2.8.2.1       Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.2.8.2.2       Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3       Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027

8.3.1        Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.2        Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.2.1      Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2.2      Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.3        Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.3.4        Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.4.1      Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.4.2      Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.4.2.1       Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.4.2.2       Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.5        China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.5.1      China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.5.2      China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.5.2.1       China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.5.2.2       China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.6        India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.6.1      India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.6.2      India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.6.2.1       India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.6.2.2       India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.7        South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.7.1      South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.7.2      South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.7.2.1       South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.7.2.2       South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.8        Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.8.1      Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.8.2      Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.3.8.2.1       Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.8.2.2       Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4       Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.4.1        Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.2        Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.2.1      Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.2.2      Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.3        Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

8.4.4        UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.1      UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.2      UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.4.2.1       UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.4.2.2       UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.4.3      Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.4      Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4.5      Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.4.5.1       Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.4.5.2       Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.5        South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.5.1      South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.5.2      South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.4.5.2.1       South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4.5.2.2       South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5       South And Central America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027

8.5.1        South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.2        South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.5.2.1      South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.2.2      South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.3        South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027,  By Country (%)

8.5.4        Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.1      Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.2      Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.5.4.2.1       Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.4.2.2       Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.4.3      Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.4      Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4.5      Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

8.5.4.5.1       Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.5.4.5.2       Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.             Cancer Tissue Diagnostics Market – Industry Landscape

9.1       Overview

9.2       Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019

9.3       Organic Growth Strategies

9.3.1        Overview

9.4       Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

9.4.1        Product Launches

9.4.1.1      Recent Product Launches By Players In The Cancer Tissue Diagnostics Market

9.4.2        Product Approvals

9.4.2.1      Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market

9.4.3        Expansion & Other Activities

9.4.3.1      Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

9.4.4        Product Enhancements

9.4.4.1      Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

9.5       Inorganic Growth Strategies

9.5.1        Overview

9.6       Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

9.6.1        Agreements

9.6.1.1      Recent Agreements By Players In The Cancer Tissue Diagnostics Market

9.6.2        Partnerships & Collaborations

9.6.2.1      Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

9.6.3        Acquisitions

9.6.3.1      Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

10.          Cancer Tissue Diagnostics Market–Key Company Profiles

10.1    Bio-Rad Laboratories, Inc.

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Financial Information

10.1.4     Product Portfolio

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2    Thermo Fisher Scientific, Inc.

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Financial Information

10.2.4     Product Portfolio

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3    F. Hoffmann-La Roche Ltd.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Financial Overview

10.3.4     Product Portfolio

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4    Abbott

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Financial Overview

10.4.4     Product Portfolio

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5    Enzo Biochem Inc.

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Financial Overview

10.5.4     Product Portfolio

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6    Agilent Technologies, Inc.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Financial Overview

10.6.4     Product Portfolio

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7    Cancer Genetics Inc.

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Financial Overview

10.7.4     Product Portfolio

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8    Merck Kgaa (Sigma-Aldrich)

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Financial Overview

10.8.4     Product Portfolio

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9    Abcam Plc.

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Financial Overview

10.9.4     Product Portfolio

10.9.5     SWOT Analysis

10.9.6     Key Developments

10.10 Danaher

10.10.1   Key Facts

10.10.2   Business Description

10.10.3   Financial Information

10.10.4   Product Portfolio

10.10.5   SWOT Analysis

10.10.6   Key Developments

11.          Appendix

11.1    About The Insight Partners

11.2    Glossary Of Terms


LIST OF TABLES

Table 1.             North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 2.             North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 3.             North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 4.             US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 5.             US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 6.             US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 7.             Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 8.             Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 9.             Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 10.          Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 11.          Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 12.          Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 13.          Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 14.          Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 15.          Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 16.          UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 17.          UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 18.          UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 19.          Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 20.          Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 21.          Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 22.          France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 23.          France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 24.          France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 25.          Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 26.          Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 27.          Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 28.          Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 29.          Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 30.          Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 31.          Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 32.          Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 33.          Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 34.          Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 35.          Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 36.          Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 37.          China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 38.          China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 39.          China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 40.          India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 41.          India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 42.          India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 43.          South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 44.          South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 45.          South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 46.          Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 47.          Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 48.          Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 49.          Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 50.          Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 51.          Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 52.          UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 53.          UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 54.          UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 55.          Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 56.          Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 57.          Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 58.          South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 59.          South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 60.          South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 61.          South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 62.          South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type  (US$ Mn)

Table 63.          South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type  (US$ Mn)

Table 64.          Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 65.          Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 66.          Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 67.          Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 68.          Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 69.          Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 70.          Recent Product Launches in the Cancer Tissue Diagnostics Market

Table 71.          Recent product Approvals in the Cancer Tissue Diagnostics Market

Table 72.          Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

Table 73.          Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

Table 74.          Recent Agreements By Players In The Cancer Tissue Diagnostics Market

Table 75.          Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

Table 76.          Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

Table 77.          Glossary of Terms, Cancer Tissue Diagnostics Market

 

LIST OF FIGURES

Figure 1.           Cancer Tissue Diagnostics Market Segmentation

Figure 2.           Cancer Tissue Diagnostics Segmentation, by Region

Figure 3.           Asia Pacific Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By Geography 2018 & 2027

Figure 4.           Global Cancer Tissue Diagnostics Market By Test Type, Market Share (%), 2018

Figure 5.           North America : PEST Analysis

Figure 6.           Europe: PEST Analysis

Figure 7.           Asia - Pacific: PEST Analysis

Figure 8.           Middle East & Africa: PEST Analysis

Figure 9.           South & Central America: PEST Analysis

Figure 10.        Most Prevalent Forms of Cancers Globally, 2018

Figure 11.        Cancer Tissue Diagnostics Market Impact Analysis of Driver and Restraints

Figure 12.        Global Cancer Tissue Diagnostics Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 13.        Global Cancer Tissue Diagnostics Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 14.        Prominent Players in the Cancer Tissue Diagnostics Market

Figure 15.        Global Cancer Tissue Diagnostics Market, by Test Type 2018 & 2027 (%)

Figure 16.        Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        North America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 28.        North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)

Figure 30.        US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.        Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.        Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.        Europe Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)

Figure 34.        Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.        Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

Figure 36.        UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.        Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.        France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.        Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.        Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.        Asia Pacific Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)

Figure 42.        Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.        Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

Figure 44.        Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.        China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46.        India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.        South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.        Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.        Middle East & Africa Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)

Figure 50.        Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.        Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

Figure 52.        UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53.        Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.        South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55.        South and Central America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)

Figure 56.        South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.        South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

Figure 58.        Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.        Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60.        Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019

Figure 61.        Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

Figure 62.        Inorganic Developments in the Cancer Tissue Diagnostics Market, 2016-2019(%)

 

The List of Companies

  1. F. Hoffmann-La Roche Ltd.
  2. Danaher Corporation
  3. Thermo Fisher Scientific Inc.
  4. Bio Rad Laboratories Inc.
  5. Abbott
  6. Enzo Life Sciences, Inc.
  7. Agilent Technologies, Inc.
  8. Cancer Genetics Inc.
  9. Merck KGaA (Sigma-Aldrich Co. LLC)
  10. Abcam plc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer tissue diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global cancer tissue diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.